The Regents of the University of Colorado, doing business as the University of Colorado-Denver, received a $188,482 Project Grant from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to conduct research on the prevalence and impacts of cannabidiol (CBD) use during pregnancy. The key objectives of this five-year grant, awarded on February 1, 2025, are to:
Estimate the prevalence of CBD use among pregnant women receiving prenatal care at the University of Colorado;
Characterize the sociodemographic, mental health, and physical health profiles of women who use CBD and/or cannabis during pregnancy; and
Explore the associations between prenatal CBD use and pregnancy/birth-related outcomes.
The study will involve surveying 800 pregnant women in their third trimester, analyzing their blood samples for cannabinoid levels, and reviewing their electronic medical records after delivery. Findings from this research aim to identify potential safety concerns related to CBD use during pregnancy.